New Delhi: The government can immediately review its policies at the Covid vaccine booster dose because scientific experts argue that the benefits of third shots may not be deserved to expand the coverage of other age groups, official source words.
However, the “dose of precautions” can continue to health workers and those with over 60 years with co-morbidity under the government’s national immunization program in accordance with the existing policies, senior officials told toi.
“Referly must be done for booster.
Policy …
must be considered.
Booster has not helped cases in any country that has given the third dose.
In addition, we will not be blind to what other countries have done.
Must see our local epidemiology and science, and our decision must be based on the judgment, “the official said.
Also read the covishield dose, Covaxin is likely to be limited to RS 275 after obtaining the Regulernew Delhi market approval: Covishield and Covaxin prices, Covid vaccines that are expected to get regular market approval from Indian drug regulators, is likely to be limited to Rs 275 per dose plus additional costs Rs 150 service, official source said.
According to them, the national national technical advisory group concerning immunization (NTagi) for Covid-19 and who has a high-level meeting on Tuesday where the booster problem is discussed in detail.
According to the official, experts from WHO and NTagi members have assessed the real world data from countries where Booster’s shot has been given.
In addition, local data is also being studied.
Experts also review the pattern of infection, viral behavior, emerging variants and viral load along with breakthroughs and reinfection.
WHO also tends to come up with a guide about the booster dose immediately.
A total of 86.87 lakh “prevention doses” have been given to health workers and front lines and over 60 years with co-morbidity since January 10, when introduced in the country.
According to the projection of the Ministry of Health, almost three health crore and frontline workers are expected to qualify for a booster shot.
In addition, 2.75 crore people in the 60-plus age group with co-morbidities are projected throughout the country.
While some studies conducted abroad have shown that booster can offer greater protection against SARS-COV2, there are also studies where initial findings show a decrease in antibody levels only a few weeks after the third dose after the dose.
“The need for hours is to develop vaccines that can prevent not only severe diseases from infection but also the spread of infection.
So that we can avoid community transmission,” the official said.
India is rather slow in supporting the amplifier.
The government has stated that every decision will be regulated by scientific evidence.
The decision to introduce booster shots was taken after increasing the number of omicron cases.
Recently, the US center for disease control and expanded prevention of feasibility for booster for adolescents.
However, many experts say that booster shots may not be a sustainable long-term strategy.
Who experts have warned that repeated booster doses of the original Covid vaccine are not a proper strategy for the variant that appears.
Covid-19: Third shot may not be given to all as skeptical experts
